Get the Stockscreener App
272.96
0.88%
-2.43
After Hours:
273.39
0.43
+0.16%
Overview
News
Price History
Option Chain
Financials
Why SYK Down?
Discussions
Forecast
Stock Split
Dividend History
Stryker Corp stock is traded at $272.96, with a volume of 2.45M.
It is down -0.88% in the last 24 hours and down -14.00% over the past month.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
See More
Previous Close:
$275.39
Open:
$275.6
24h Volume:
2.45M
Relative Volume:
0.95
Market Cap:
$104.70B
Revenue:
$25.27B
Net Income/Loss:
$3.34B
P/E Ratio:
31.62
EPS:
8.6334
Net Cash Flow:
$4.57B
1W Performance:
+1.19%
1M Performance:
-14.00%
6M Performance:
-17.13%
1Y Performance:
-25.04%
1-Day Range:
$271.34
$278.51
1-Week Range:
$268.69
$280.17
52-Week Range:
$267.00
$392.55
Stryker Corp Stock (SYK) Company Profile
Name
Stryker Corp
Sector
Industry
Phone
(269) 385-2600
Address
1941 STRYKER WAY, PORTAGE, MI
Compare SYK vs ABT, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
272.96 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
ABT
Abbott Laboratories
|
96.69 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.44 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
43.23 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.19 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-26 | Initiated | Leerink Partners | Outperform |
| Feb-20-26 | Initiated | William Blair | Outperform |
| Jan-27-26 | Resumed | TD Cowen | Hold |
| Jan-06-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-19-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Sep-18-25 | Initiated | Rothschild & Co Redburn | Neutral |
| Feb-26-25 | Resumed | Citigroup | Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Outperform |
| May-30-24 | Initiated | Goldman | Neutral |
| May-22-24 | Upgrade | Needham | Hold → Buy |
| Jan-31-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-05-23 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-25-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-28-22 | Upgrade | Edward Jones | Hold → Buy |
| Jul-21-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-11-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-15-22 | Resumed | Evercore ISI | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| Jul-28-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jun-01-21 | Upgrade | Evercore ISI | In-line → Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Oct-06-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-13-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-01-20 | Downgrade | Goldman | Buy → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Hold |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-30-19 | Reiterated | BTIG Research | Buy |
| Nov-05-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-19 | Reiterated | BofA/Merrill | Buy |
| Jul-02-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-30-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-16-18 | Initiated | BTIG Research | Buy |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-27-18 | Reiterated | Stifel | Buy |
View All
Stryker Corp Stock (SYK) Latest News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp.SYK - PR Newswire
TD Cowen cuts target for Stryker stock from USD 355.00 to USD 298.00 - AD HOC NEWS
Stryker to announce third quarter 2026 financial results - Yahoo! Finance Canada
CEUX:SYKd Dividend: Does Stryker Corp Pay a Dividend? - GuruFocus
Stryker Price Target Cut to $330.00/Share From $360.00 by Stifel - Moomoo
Stryker (CEUX:SYKD) Graham Number : €N/A (As of Jun. 2026) - GuruFocus
Insiders At Stryker Sold US$582m In Stock, Alluding To Potential Weakness - Moomoo
Stryker stock faces analyst cuts as Stifel lowers target - AD HOC NEWS
Stifel cuts Stryker stock price target on revenue pressures - Investing.com
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
Stryker stock gains 1.77 percent as quarterly growth holds - AD HOC NEWS
Form 4 Stryker Corporation For: 28 September By Investing.com - Investing.com Canada
A 109-share employee stock plan transfer leaves Stryker (SYK) CFO holding 3,661 shares directly. - Stock Titan
Stryker Corp Lobbyists, 2021 - OpenSecrets
Is ResMed A Better Way Than Stryker To Own Medical Device Growth? - Yahoo Finance
Realty Income, Stryker and more dividends 2026 • Vienna Stock Exchange - Wiener Börse
Stryker stock trades at USD 270.92, down 0.91 percent in New York trading - AD HOC NEWS
ELFA Names James Cress Acting President & CEO - GlobeNewswire Inc.
Stryker Corp (CEUX:SYKd) Stock Price, Trades & News - GuruFocus
Form 4 Stryker Corporation For: 25 September By Investing.com - Investing.com Canada
Envestnet Asset Management Inc. Purchases 70,634 Shares of Stryker Corporation $SYK - MarketBeat
Stryker Corp. stock slips 1.2 percent ahead of the open - AD HOC NEWS
Stryker Corporation (SYK) Options ChainYahoo Finance - ca.finance.yahoo.com
Stryker faces investigation after CEO reveals o... - Pluang
Stryker Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Under a matrimonial settlement, Stryker (SYK) CFO Wells Preston Wendell transferred shares twice. - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Is Investigating Stryker Corporation (SYK) And Encourages Shareholders to Connect - ACCESS Newswire
What Does General Dynamics (GD) Winning New Stryker Work Mean Through 2028? - Yahoo Finance
QRG Capital Management Inc. Decreases Holdings in Stryker Corporation $SYK - MarketBeat
Intuitive Surgical vs. Stryker: Which MedTech Stock Is the Better Buy Now? - theglobeandmail.com
Here's Why You Should Hold Stryker Stock in Your Portfolio for Now - Yahoo Finance
Stryker stock steadies after target cuts and earnings gains - AD HOC NEWS
Stryker stock heads into the open after a 0.33 percent gain - AD HOC NEWS
Stryker stock falls 21.6 percent as TD Cowen cuts target - AD HOC NEWS
Stryker Corporation $SYK Shares Bought by State Street Corp - MarketBeat
Stryker (SYK) Foot And Ankle Push Keeps Undervalued Narrative In Focus - Yahoo Finance
TD Cowen Maintains Stryker Corp(SYK.US) With Hold Rating, Cuts Target Price to $298 - Moomoo
Stryker (SYK) Expanded Its Foot And Ankle Portfolio - Yahoo Finance
TD Cowen cuts Stryker stock price target to $298 on margin concerns - Investing.com
Jefferies Adjusts Price Target on Stryker to $405 From $440, Keeps Buy Rating - marketscreener.com
Stryker stock before the bell after a 0.36 percent drop - AD HOC NEWS
Stryker (SYK): The Healthcare Stocks Name Everyone's Asking About - Kalkine Media
Stryker stock gains from Raymond James support - AD HOC NEWS
Raymond James Adjusts Price Target on Stryker to $330 From $370, Keeps Outperform Rating - Yahoo Finance
Stryker Corp. stock heads into the open without fresh session data - AD HOC NEWS
Stryker Corp. stock holds steady amid lack of fresh data - AD HOC NEWS
Stryker Corp. stock underperforms Friday when compared to competitors - marketwatch.com
Securities firm investigates Stryker for possib... - Pluang
Stryker (NYSE:SYK) Given New $385.00 Price Target at Canaccord Genuity Group - MarketBeat
Stryker Is Maintained at Buy by Canaccord Genuity - Moomoo
Nykredit A S Purchases Shares of 282,407 Stryker Corporation $SYK - marketbeat.com
Stryker Corp Stock (SYK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.17%
0.96%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):